ArticleFrontiers in immunology2019

Enhanced Expression of CD47 Is Associated With Off-Target Resistance to Tyrosine Kinase Inhibitor Gefitinib in NSCLC.

Annunziata Nigro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.